Cargando…

MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers

Chemo-resistance is an important barrier to effective treatment of ovarian cancer. Poly (ADP-ribose) polymerase (PARP) inhibitors are currently promising targeted drugs used to treat BRCA-mutant ovarian cancer. Ovarian cancer patients with BRCA 1/2 mutations appear to benefit better from PARP inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yue, Wu, Jing, Dong, Xiaoying, Zhang, Jingzi, Meng, Chao, Liu, Guoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770486/ https://www.ncbi.nlm.nih.gov/pubmed/33360300 http://dx.doi.org/10.1016/j.tranon.2020.100987

Ejemplares similares

MicroRNA-506-3p inhibits ovarian cancer metastasis by down-regulating the expression of EZH2
por: Sun, Yue, et al.
Publicado: (2022)

MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
por: Zhang, Yi, et al.
Publicado: (2015)

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

MicroRNA‑506 regulates apoptosis in retinoblastoma cells by targeting sirtuin 1
por: Song, Zhidu, et al.
Publicado: (2019)

MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2
por: Liang, Tian-Song, et al.
Publicado: (2019)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Retraction Note: MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by downregulating LHX2
por: Liang, Tian-Song, et al.
Publicado: (2021)

Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer
por: Pandya, Deep, et al.
Publicado: (2014)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer
por: Raspaglio, Giuseppina, et al.
Publicado: (2023)

MicroRNA-361-3p Inhibit the Progression of Lymphoma by the Wnt/β-Catenin Signaling Pathway
por: Zhou, Hui, et al.
Publicado: (2020)

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
por: Liu, Yunyun, et al.
Publicado: (2018)

PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
por: Dickson, Kristie-Ann, et al.
Publicado: (2021)

Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway
por: Dai, Jun, et al.
Publicado: (2019)

Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP
por: Lei, Ruilin, et al.
Publicado: (2016)

MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2
por: Zhou, Fenmei, et al.
Publicado: (2016)

The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
por: Wang, Jieyu, et al.
Publicado: (2023)

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
por: Moghbeli, Meysam
Publicado: (2021)

MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin
por: SU, JUAN, et al.
Publicado: (2011)

MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer
por: Ibrahim, Fateen Farhana, et al.
Publicado: (2015)

MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2
por: Li, Bo, et al.
Publicado: (2019)

Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
por: Sahin, Irem Durmaz, et al.
Publicado: (2019)

Retraction Note: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway
por: Dai, Jun, et al.
Publicado: (2022)

Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2
por: Xu, Haiyang, et al.
Publicado: (2019)

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
por: Yamaguchi, Hirohito, et al.
Publicado: (2017)

PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
por: Sedley, Shoshana, et al.
Publicado: (2022)

MicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway
por: Zhang, Qiang, et al.
Publicado: (2018)

Roles of Wnt/β-catenin signaling pathway related microRNAs in esophageal cancer
por: Chu, Chao-Yang, et al.
Publicado: (2022)

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
por: Yang, Junzheng, et al.
Publicado: (2017)

Extracellular microRNA profiling for prognostic prediction in patients with high‐grade serous ovarian carcinoma
por: Yoshida, Kosuke, et al.
Publicado: (2021)

Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2
por: Wang, Gui-Jun, et al.
Publicado: (2019)

Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
por: Reid, Brett M., et al.
Publicado: (2021)

Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
por: Jia, Yaxun, et al.
Publicado: (2022)

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
por: Bound, Nirashaa T., et al.
Publicado: (2022)

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer
por: Vendrell, Julie A., et al.
Publicado: (2023)

MicroRNA-16 inhibits migration and invasion via regulation of the Wnt/β-catenin signaling pathway in ovarian cancer
por: Li, Nan, et al.
Publicado: (2019)

RWR-algorithm-based dissection of microRNA-506-3p and microRNA-140-5p as radiosensitive biomarkers in colorectal cancer
por: Liao, Fei, et al.
Publicado: (2020)

The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt/β-catenin pathway
por: Chen, Linwei, et al.
Publicado: (2016)

Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer
por: Ghobashi, Ahmed H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5kb888dpfa1oq7n3g6jqspc8he